An immunosuppressant, FK506, protects against neuronal dysfunction and death but has no effect on electrographic and behavioral activities induced by systemic kainate

Neuroscience

Volumn 86, Issue 3, 1998, Pages 855-865

  Moriwaki, A ^a   Lu, Y F ^a   Tomizawa, K ^a   Matsui, H ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cell death; Fiber volley; FK506; Hippocampus; Kainate; Long term potentiation

Indexed keywords

KAINIC ACID; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM POTENTIATION; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

AFFERENT PATHWAYS; AMYGDALA; ANIMALS; BRAIN; CELL DEATH; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; IMMUNOSUPPRESSIVE AGENTS; KAINIC ACID; MALE; NERVE FIBERS; NEURONS; RATS; RATS, WISTAR; REGRESSION ANALYSIS; SEIZURES; TACROLIMUS; TIME FACTORS;

EID: 0031836346     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00071-2     Document Type: Article

References (60)

1. Ben-Ari Y. (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14, 375-403.
2. Ben-Ari Y., Tremblay E., Riche D., Ghilini G. and Naquet R. (1981) Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline, or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6, 1361-1391.
3. Burnashev N., Zhou Z., Neher E. and Sakmann B. (1995) Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes. J. Physiol. 485, 403-418.
4. Cantallops I. and Routtenberg A. (1996) Rapid induction by kainic acid of both axonal growth and F1/GAP-43 protein in the adult rat hippocampal granule cells. J. comp. Neurol. 366, 303-319.
5. Chittajallu R., Vignes M., Dev K. K., Barnes J. M., Collingridge G. L. and Henley J. M. (1996) Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature 379, 78-81.
6. Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
7. Choi D. W. (1992) Excitotoxic cell death. J. Neurobiol. 23, 1261-1276.
8. Cohen A. S. and Abraham W. C. (1996) Facilitation of long-term potentiation by prior activation of metabotropic glutamate receptors. J. Neurophysiol. 76, 953-962.
9. Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
10. Crépel V., Hammond C., Chinestra P., Diabira D. and Ben-Ari Y. (1993) A selective LTP of NMDA receptor-mediated currents induced by anoxia in CA1 hippocampal neurons. J. Neurophysiol. 70, 2045-2055.
11. Dawson T. M., Steiner J. P., Dawson V. L., Dinerman J. L., Uhl G. R. and Snyder S. H. (1993) Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. natn. Acad. Sci. U.S.A. 90, 9808-9812.
12. Faden A. I. and Simon R. P. (1988) A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neurol. 23, 623-626.
13. Ferkany J. W., Zaczek R. and Coyle J. T. (1982) Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature 298, 757-759.
14. Filipkowski R. K., Hetman M., Kaminska B. and Kaczmarek L. (1994) DNA fragmentation in rat brain after intraperitoneal administration of kainate. NeuroReport 5, 1538-1540.
15. Foster A. C., Mena E. E., Monaghan D. T. and Cotman C. W. (1981) Synaptic localization of kainic acid binding sites. Nature 289, 73-75.
16. Franclk J. E. and Roberts D. L. (1990) Combined kainate and ischemia produces 'mesial temporal sclerosis'. Neurosci. Lett. 118, 159-163.
17. Gold S. J., Hennegriff M., Lynch G. and Gall C. M. (1996) Relative concentrations and seizure-induced changes in mRNAs encoding three AMPA receptor subunits in hippocampus and cortex. J. comp. Neurol. 365, 541-555.
18. Gwang B. J., Koh J. Y., Demaro J. A., Ying H. S., Jacquin M. and Choi D. W. (1997) Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience 77, 393-401.
19. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252, 851-853.
20. Harding M. W., Galat A., Uehling D. E. and Schreiber S. L. (1989) A receptor for immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341, 758-760.
21. Heggli D. E. and Malthe-Sorenssen D. (1982) Systemic injection of kainic acid: effect on neurotransmitter markers in piriform cortex, amygdaloid complex and hippocampus and protection by cortical lesioning and anticonvulsants. Neuroscience 7, 1257-1264.
22. Ide T., Morikawa E. and Kirino T. (1996) An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the Mongolian gerbil. Neurosci. Lett. 204, 157-160.
23. Iino M., Ozawa S. and Tsuzuki K. (1990) Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. J. Physiol. 424, 151-165.
24. 2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron 12, 1281-1289.
25. Liu J., Farmer J. D. Jr, Lane W. S., Friedman J., Weissman I. and Schreiber S. L. (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
26. Loh C., Shaw K. T.-Y., Carew J., Viola J. P. B., Luo C., Perrino B. A. and Rao A. (1996) Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J. biol. Chem. 271, 10,884-10,891.
27. Lothman E. W. and Collins R. C. (1981) Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 218, 299-318.
28. 2+/calmodulin-dependent phosphatase inhibitor, inhibits the induction of long-term potentiation in the rat hippocampus. Neurosci. Lett. 205, 103-106.
29. Lu Y.-F., Tomizawa K., Moriwaki A., Hayashi Y., Tokuda M., Itano T., Hatase O. and Matsui H. (1996) Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation, in the rat hippocampus. Brain Res. 729, 142-146.
30. 2+ influx underlies potent induction of injury. J. Neurosci. 16, 5457-5465.
31. MacGregor D. G., Higgins M. J., Jones P. A., Maxwell W. L., Watson M. W., Graham D. I. and Stone T. W. (1996) Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus. Brain Res. 727, 133-144.
32. Matsui H., Doi A., Itano T., Shimada M., Wang J. H. and Hatase O. (1987) Immunohistochemical localization of calcineurin, calmodulin-stimulated phosphatase, in the rat hippocampus using a monoclonal antibody. Brain Res. 402, 193-196.
33. 3H]glutamate-binding sites in rat brain. J. Neurosci. 5, 2909-2919.
34. Moriwaki A., Lu Y.-F., Hayashi Y., Tomizawa K., Tokuda M., Itano T., Hatase O. and Matsui H. (1996) Immunosuppressant FK506 prevents mossy fiber sprouting induced by kindling stimulation. Neurosci. Res. 25, 191-194.
35. ++ influx into striatal neurons by kainic acid. J. Pharmac. exp. Ther. 249, 184-193.
36. Nishiyama K., Kwak S., Takekoshi S., Watanabe K. and Kanazawa I. (1996) In situ nick end-labeling detects necrosis of hippocampal pyramidal cells induced by kainic acid. Neurosci. Lett. 212, 139-142.
37. Olney J. W. (1978) Neurotoxicity of Excitatory Amino Acids. Raven, New York.
38. Ong W. Y., Leong S. K., Garey L. J., Reynolds R. and Liang A. W. (1996) An immunocytochemical study of glutamate receptors and glutamine synthetase in the hippocampus of rats injected with kainate. Expl Brain Res. 109, 251-267.
39. 2+ in toxic cell killing. Trends pharmac. Sci. 10, 281-285.
40. Palmer A. M., Reiter C. T. and Botscheller M. (1992) Comparison of the release of exogenous and endogenous excitatory amino acids from rat cerebral cortex. Ann. N. Y. Acad. Sci. 648, 361-364.
41. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
42. Pellegrini-Giampietro D. E., Zukin R. S., Bennett M. V. L., Cho S. and Pulsinelli W. A. (1992) Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. natn. Acad. Sci. U.S.A. 89, 10,499-10,503.
43. Pollard H., Charriaut-Marlangue C., Cantagrel S., Represa A., Robain O., Moreau J. and Ben-Ari Y. (1994) Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience 63, 7-18.
44. Portera-Cailliau C., Price D. L. and Martin L. J. (1997) Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J. comp. Neural. 378, 70-87.
45. Pruss R. M., Akeson R. L., Racke M. M. and Wilburn J. L. (1991) Agonist-activated cobalt uptake identifies divalent cation-permeable kainate receptors on neurons and glial cells. Neuron 7, 509-518.
46. Pulsinelli W. A., Brierley J. B. and Plum F. (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11, 491-498.
47. Schwarcz R., Foster A. C., French E. D., Whetsell W. O. Jr and Köhler C. (1984) Excitotoxic models for neurodegenerative disorders. Life Sci. 35, 19-32.
48. Schwob J. E., Fuller T., Price J. L. and Olney J. W. (1980) Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience 5, 991-1014.
49. Shahi K. and Baudry M. (1992) Increasing binding affinity of agonists to glutamate receptors increases synaptic responses at glutamatergic synapses. Proc. natn. Acad. Sci. U.S.A. 89, 6881-6885.
50. Sharkey J. and Butcher S. P. (1994) Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371, 336-339.
51. 2+-activated cell death in mammalian cells. J. Cell Biol. 131, 735-743.
52. Siekierka J. J., Hung S. H. Y., Poe M., Lin C. S. and Sigal N. H. (1989) A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-propyl isomerase activity but is distinct from cyclophilin. Nature 341, 755-757.
53. Simonian N. A., Getz R. L., Leveque J. C., Konradi C. and Coyle J. T. (1996) Kainate induces apoptosis in neurons. Neuroscience 74, 675-683.
54. Sperk G., Lassmann H., Baran H., Kish S. J., Seitelberger F. and Hornykiewicz O. (1983) Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 10, 1301-1315.
55. Steiner J. P., Dawson T. M., Fotuhi M., Glatt C. E., Snowman A. M., Cohen N. and Snyder S. H. (1992) High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358, 584-587.
56. Tokime T., Nozaki K. and Kikuchi H. (1996) Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. Neurosci. Lett. 206, 81-84.
57. Tsintsadze T., Lozovaya N., Klishin A. and Krishtal O. (1996) NMDA receptor-mediated synapses between CA1 neurons: activation by ischaemia. NeuroReport 7, 2679-2682.
58. Weiss J. H., Hartley D. M., Koh J. and Choi D. W. (1990) The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science 247, 1474-1477.
59. Weiss S., Cataltepe O. and Cole A. J. (1996) Anatomical studies of DNA fragmentation in rat brain after systemic kainate administration. Neuroscience 74, 541-551.
60. Yazdanbakhsh K., Choi J.-W., Li Y., Lau L. F. and Choi Y. (1995) Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77. Proc. natn. Acad. Sci. U.S.A. 92, 437-441.